Literature DB >> 14972555

Generation and characterization of P gene-deficient rabies virus.

Youko Shoji1, Satoshi Inoue, Kazuo Nakamichi, Ichiro Kurane, Takeo Sakai, Kinjiro Morimoto.   

Abstract

Rabies virus (RV) deficient in the P gene was generated by reverse genetics from cDNA of HEP-Flury strain lacking the entire P gene. The defective virus was propagated and amplified by rescue of virus, using a cell line that complemented the functions of the deficient gene. The P gene-deficient (def-P) virus replicated its genome and produced progeny viruses in the cell lines that constitutively expressed the P protein, although it grew at a slightly retarded rate compared to the parental strain. In contrast, no progeny virus was produced in the infected host when the def-P virus-infected cells that did not express the P protein. However, we found that the def-P virus had the ability to perform primary transcription (by the virion-associated polymerase) in the infected host without de novo P protein synthesis. The def-P virus was apathogenic in adult and suckling mice, even when inoculated intracranially. Inoculation of def-P virus in mice induced high levels of virus-neutralizing antibody (VNA) and conferred protective immunity against a lethal rabies infection. These results demonstrate the potential utility of gene-deficient virus as a novel live attenuated rabies vaccine.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14972555     DOI: 10.1016/j.virol.2003.10.001

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  18 in total

Review 1.  Experimental rabies vaccines for humans.

Authors:  James P McGettigan
Journal:  Expert Rev Vaccines       Date:  2010-10       Impact factor: 5.217

2.  Dynamics of viral RNA synthesis during measles virus infection.

Authors:  Sébastien Plumet; W Paul Duprex; Denis Gerlier
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

3.  Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene.

Authors:  Jonathan Cenna; Gene S Tan; Amy B Papaneri; Bernhard Dietzschold; Matthias J Schnell; James P McGettigan
Journal:  Vaccine       Date:  2008-09-18       Impact factor: 3.641

4.  Reverse genetics of rabies virus: new strategies to attenuate virus virulence for vaccine development.

Authors:  Shimao Zhu; Hui Li; Chunhua Wang; Farui Luo; Caiping Guo
Journal:  J Neurovirol       Date:  2015-05-21       Impact factor: 2.643

5.  Rabies virus-induced activation of mitogen-activated protein kinase and NF-kappaB signaling pathways regulates expression of CXC and CC chemokine ligands in microglia.

Authors:  Kazuo Nakamichi; Megumi Saiki; Makoto Sawada; Mutsuyo Takayama-Ito; Yutaka Yamamuro; Kinjiro Morimoto; Ichiro Kurane
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

6.  A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodies.

Authors:  Milosz Faber; Elaine W Lamirande; Anjeanette Roberts; Amy B Rice; Hilary Koprowski; Bernhard Dietzschold; Matthias J Schnell
Journal:  J Gen Virol       Date:  2005-05       Impact factor: 3.891

Review 7.  Status of antiviral therapeutics against rabies virus and related emerging lyssaviruses.

Authors:  Venice Du Pont; Richard K Plemper; Matthias J Schnell
Journal:  Curr Opin Virol       Date:  2019-02-10       Impact factor: 7.090

8.  Rabies virus (RV) glycoprotein expression levels are not critical for pathogenicity of RV.

Authors:  Christoph Wirblich; Matthias J Schnell
Journal:  J Virol       Date:  2010-11-10       Impact factor: 5.103

9.  Rabies virus stimulates nitric oxide production and CXC chemokine ligand 10 expression in macrophages through activation of extracellular signal-regulated kinases 1 and 2.

Authors:  Kazuo Nakamichi; Satoshi Inoue; Tomohiko Takasaki; Kinjiro Morimoto; Ichiro Kurane
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

10.  Immunogenicity studies in carnivores using a rabies virus construct with a site-directed deletion in the phosphoprotein.

Authors:  Ad Vos; Karl-Klaus Conzelmann; Stefan Finke; Thomas Müller; Jens Teifke; Anthony R Fooks; Andreas Neubert
Journal:  Adv Prev Med       Date:  2011-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.